Thirty-fourth meeting of the Expert Committee on Drug Dependence
Agenda
Before the meeting started, an information meeting was held where a number of NGOs and others were represented to inform the members of the Expert Committee on their views with regard to topics on the agenda. Views on buprenorphine and tramadol were presented.
1. OPENING OF MEETING
2. PROCEDURAL MATTERS
2.1 Election of chairperson, vice-chairperson and rapporteur
2.2 Adoption of agenda
3. PRESENTATION BY EMCDDA
4. CRITICAL REVIEW OF PSYCHOACTIVE SUBSTANCES
-
4.1 butorphanol (INN)
pdf, 258kb -
4.2 dronabinol (INN)
pdf, 296kb -
4.3 ketamine (INN)
pdf, 187kb -
4.4 khat (Catha edulis Forsk.)
pdf, 159kb -
4.5 zopiclone (INN)
pdf, 203kb
5. PRE-REVIEW
* The review report for tramadol was written as a critical review report, but the Committee decided for procedural reasons that this topic should be discussed as a pre-review.
6. PENDING MATTERS SINCE THIRTY-THIRD MEETING
7. OTHER ISSUES
-
7.1 SSRIs
pdf, 14kb -
7.2 Use of pharmacovigilance data for dependency assessment
pdf, 17kb
(procedures and methodology)
7.3 Identification of substances for future pre-review